Sino Biopharm has a good financial position. As of December 2024, it has CNY 9.6 billion in cash on hand and CNY 9.6 billion in debt. Total debt outstanding is 14.7% of its total assets. Its capital ...

Syngenta’s Sustainable Sourcing Programme strives to promote regenerative and traceable agriculture in Argentina and enhance ...

A new report has uncovered how investors can most effectively foster shareholder engagement on environmental, societal and ...

As diplomatic tensions continue between Canada and the United States, a travel group says Islanders are rethinking their travel plans, opting for alternative vacation destinations that are either ...